Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Matrix metalloproteinase (MMP) multipack-1

 
BML-AK013-0001 1 Kit 681.00 USD
Do you need bulk/larger quantities?
 
The MMP multipack-1 contains 10µg each of five highly active recombinant MMP catalytic domains: MMP-1, MMP-2, MMP-8, MMP-9, and MMP-13.

Product Specification

Applications:FUNC, HTS
 
Application Notes:Enzyme regulation and kinetics, comparative studies of substrate or inhibitor specificities, cleavage of target proteins. Assay or digest conditions can vary widely, but concentrations for the MMP enzymes can range between 10 and 300nM, or higher. Reaction temperatures can be between 25 and 37°C, and reaction times can range from 10 min to overnight, again depending on application and substrate. A typical assay buffer is 50mM HEPES, pH 7.0, 10mM CaCl2, 0.05% Brij-35. For more information, contact Enzo Life Sciences Technical Support.
 
Kit/Set Contains:

Contains 10µg of each enzyme, provided in a screw-cap microfuge tube.

MMP-1 (catalytic domain) (human), (recombinant) (Prod. No. BML-SE180),

MMP-2 (catalytic domain) (human), (recombinant) (Prod. No. BML-SE237),

MMP-8 (catalytic domain) (human), (recombinant) (Prod. No. BML-SE255),

MMP-9 (catalytic domain) (human), (recombinant) (Prod. No. BML-SE360),

MMP-13 (catalytic domain) (human), (recombinant) (Prod. No. BML-SE246).

 
Formulation:For MMP-1, MMP-2, MMP-8, and MMP-13:
Liquid. 0.1µg/µl in 50mM TRIS, pH 7.5, containing 5mM CaCl2, 300mM NaCl, 20µM ZnCl2, 30% glycerol, 0.5% Brij-35.

For MMP-9:
Liquid. In 50mM TRIS, pH 7.5, containing 1mM CaCl2, 300mM NaCl, 5µM ZnCl2, 0.1% Brij-35 and 15% glycerol.
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Shipped on Dry Ice
 
Long Term Storage:-80°C
 
Scientific Background:The matrix metalloproteinases, or MMPs, are extracellular proteases that function at a neutral pH to cleave a wide variety of substrates. These include basement membrane and extracellular matrix components, growth and death factors, cytokines, and cell and matrix adhesion molecules. The broad range of substrate specificities and expression patterns of MMPs results in their involvement in many different processes, both normal and pathological. Aberrant expression has been noted in cancer, angiogenesis, arthritis, inflammation, periodontal disease, emphysema, multiple sclerosis, pre-eclampsia, and chronic wounds, among others. The general structure of an MMP protein consists of a pre domain to direct secretion from the cell, a pro domain, a catalytic domain, and a C-terminal hemopexin domain. The catalytic site involves a coordinately-bound zinc ion. The inactive, or zymogen, form of the enzyme is activated by disruption of one of the coordinate bonds, usually via proteolytic removal of the pro domain.
 

General Literature References

Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.: V. Noë et al.; J. Cell Sci. 114, 111 (2001),
Extrinsic regulators of epithelial tumor progression: metalloproteinases.: G. Bergers & L.M. Coussens; Curr. Opin. Genet. Dev. 10, 120 (2000),
Matrix metalloproteinases: biologic activity and clinical implications.: A.R. Nelson et al.; J. Clin. Oncol. 18, 1135 (2000),
Metalloproteinases and TIMPs.: J.F. Woessner & H. Nagase; Oxford University Press (2000),
Truncated active matrix metalloproteinase-8 gene expression in HepG2 cells is active against native type I collagen.: F. Siller-López et al.; J. Hepatol. 33, 758 (2000),
Structural properties of matrix metalloproteinases.: W. Bode et al.; Cell. Mol. Life Sci. 55, 639 (1999),
Matrix metalloproteinase degradation of extracellular matrix: biological consequences.: S.D. Shapiro; Curr. Opin. Cell Biol. 10, 602 (1998),
Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?: G. Murphy & V. Knäuper; Matrix Biol. 15, 511 (1997),
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.: V. Knäuper et al.; J. Biol. Chem. 272, 7608 (1997),

Related Products

Matrix metalloproteinase (MMP) multipack-2 

FUNC, HTS | Print as PDF
 
BML-AK014-0001 1 Kit 661.00 USD
Do you need bulk/larger quantities?
 

MMP-1 (catalytic domain) (human), (recombinant) 

Produced in E. coli. Active Matrix Metalloproteinase-1 (MMP-1, interstitial collagenase, fibroblast collagenase) catalytic domain from human cDNA. The enzyme consists of the catalytic domain of human MMP-1 (Phe100-Gln268) with a C-terminal purification tag., ≥95% (SDS-PAGE) | Print as PDF
 
BML-SE180-0010 10 µg 384.00 USD
Do you need bulk/larger quantities?
 

MMP-2 (catalytic domain) (human), (recombinant) 

Produced in yeast. Active recombinant matrix metalloproteinase-2 (MMP-2, gelatinase A, 72kDa type IV collagenase) cloned from human cDNA. The enzyme consists of residues Tyr110-Asp452, which comprises the catalytic/fibronectin domain of human MMP-2, with a C-terminal purification tag. , ≥90% (SDS-PAGE) | Print as PDF
 
BML-SE237-0010 10 µg 384.00 USD
Do you need bulk/larger quantities?
 

MMP-8 (catalytic domain) (human), (recombinant) 

Produced in E. coli. Active Matrix Metalloproteinase-8 (MMP-8, neutrophil collagenase, collagenase-2) catalytic domain from human cDNA. The enzyme consists of the catalytic domain of human MMP-8 (Phe99-Gln269, NM_002424) with a C-terminal purification tag. This represents a naturally-occurring active form of MMP-8 which lacks the C-terminal hemopexin domain1. MMPs lacking this domain cannot cleave native collagens; however, activity toward other targets such as gelatin, casein, or peptide substrates is unaffected., ≥90% (SDS-PAGE) | Print as PDF
 
BML-SE255-0010 10 µg 384.00 USD
Do you need bulk/larger quantities?
 

MMP-9 (catalytic domain) (human), (recombinant, E. coli) 

Produced in E. coli. Active recombinant matrix metalloproteinase-9 (MMP-9, gelatinase B, 92 kDa type IV collagenase) cloned from human cDNA. The enzyme consists of residues Phe107-Pro449 (NM_004994), which comprises the catalytic/fibronectin domain of human MMP-9, with a C-terminal purification tag. This represents a naturally-occurring active form of MMP-9 which lacks the C-terminal hemopexin domain. Activity toward its targets, such as gelatin, casein, or peptide substrates, is unaffected., ≥95% (SDS-PAGE) | Print as PDF
 
BML-SE360-0010 10 µg 384.00 USD
Do you need bulk/larger quantities?
 

MMP-13 (catalytic domain) (human), (recombinant) 

Produced in E. coli. Active Matrix Metalloproteinase-13 (MMP-13, collagenase-3) catalytic domain from human cDNA. The enzyme consists of the catalytic domain of human MMP-13 (Tyr104-Asn274, NM_002427) with a C-terminal purification tag. This represents a naturally-occurring active form of MMP-13 which lacks the C-terminal hemopexin domain. MMPs lacking this domain cannot cleave native collagens; however, activity toward other targets such as gelatin, casein, or peptide substrates is unaffected., ≥95% (SDS-PAGE) | Print as PDF
 
BML-SE246-0010 10 µg 384.00 USD
Do you need bulk/larger quantities?
 

Related Literature

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,